Polaris Office Corp. (KOSDAQ:041020)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	291,147	268,789	218,609	61,683	105,432	80,830
Market Cap Growth	-26.15%	22.96%	254.41%	-41.49%	30.44%	32.92%
Enterprise Value	480,838	517,169	272,653	43,838	99,665	68,170
Last Close Price	5860.00	5410.00	4400.00	1300.00	2595.00	2160.00
PE Ratio	45.93	38.04	10.26	4.71	-	-
Forward PE	-	3.90	3.90	3.90	3.90	3.90
PS Ratio	0.96	0.97	2.03	2.55	4.59	4.15
PB Ratio	0.67	0.62	0.85	0.96	2.61	2.50
P/TBV Ratio	7.65	7.38	4.34	1.02	2.76	2.70
P/FCF Ratio	52.33	55.41	27.54	180.17	-	-
P/OCF Ratio	18.86	14.84	14.47	39.12	233.88	-
PEG Ratio	-	0.07	0.07	0.07	0.07	0.07
EV/Sales Ratio	1.58	1.87	2.53	1.81	4.34	3.50
EV/EBITDA Ratio	30.68	36.01	26.97	16.03	30.13	-
EV/EBIT Ratio	106.92	120.27	43.64	24.95	40.81	-
EV/FCF Ratio	86.43	106.62	34.35	128.04	-	-
Debt / Equity Ratio	0.06	0.06	0.07	0.07	0.18	0.31
Debt / EBITDA Ratio	1.53	1.68	1.65	1.62	2.21	-
Debt / FCF Ratio	4.33	4.97	2.10	12.95	-	-
Asset Turnover	0.65	0.66	0.55	0.37	0.44	0.46
Inventory Turnover	4.70	4.87	-	-	-	-
Quick Ratio	3.25	3.29	3.77	3.00	0.94	0.99
Current Ratio	4.27	4.33	4.42	3.35	1.26	1.42
Return on Equity (ROE)	4.19%	5.39%	13.96%	24.33%	-0.79%	-3.26%
Return on Assets (ROA)	0.61%	0.64%	1.99%	1.70%	2.95%	-11.20%
Return on Capital (ROIC)	0.69%	0.73%	2.28%	1.88%	3.39%	-13.52%
Return on Capital Employed (ROCE)	1.00%	1.00%	2.30%	2.60%	6.00%	-
Earnings Yield	2.18%	2.63%	9.75%	21.25%	-0.20%	-0.13%
FCF Yield	1.91%	1.80%	3.63%	0.56%	-0.04%	-6.60%
Payout Ratio	18.42%	16.53%	-	-	-	-
Buyback Yield / Dilution	-0.05%	-0.18%	-3.00%	-25.11%	-2.84%	-

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.